SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹33 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹31 Cr |
What is the latest Total Non-Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹31 Cr |
How is Total Non-Current Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 15.24 | |
| Mar2024 | ₹29 Cr | 15.72 | |
| Mar2023 | ₹25 Cr | 29.23 | |
| Mar2022 | ₹19 Cr | -37.22 | |
| Mar2021 | ₹31 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,536.4 Cr | -0.8% | -10% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -0.8% |
-10% |
-4.7% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses